{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:57:21Z","timestamp":1793793441638,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["IG 27825"],"award-info":[{"award-number":["IG 27825"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF 2022-14364"],"award-info":[{"award-number":["KWF 2022-14364"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202107040034"],"award-info":[{"award-number":["202107040034"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["IG 24815"],"award-info":[{"award-number":["IG 24815"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024870","name":"Exacte en Natuurwetenschappen","doi-asserted-by":"publisher","award":["OCENW.XS21.2.003"],"award-info":[{"award-number":["OCENW.XS21.2.003"]}],"id":[{"id":"10.13039\/501100024870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016033","name":"Nederlandse Vereniging voor Gastroenterologie","doi-asserted-by":"publisher","award":["NVGE-2022"],"award-info":[{"award-number":["NVGE-2022"]}],"id":[{"id":"10.13039\/100016033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016033","name":"Nederlandse Vereniging voor Gastroenterologie","doi-asserted-by":"publisher","award":["CA22125"],"award-info":[{"award-number":["CA22125"]}],"id":[{"id":"10.13039\/100016033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001718","name":"Netherlands Organization for International Cooperation in Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022AHM4AA"],"award-info":[{"award-number":["2022AHM4AA"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","award":["70114101"],"award-info":[{"award-number":["70114101"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["493345156"],"award-info":[{"award-number":["493345156"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014810","name":"Fondazione di Sardegna","doi-asserted-by":"publisher","award":["HDMA-380801"],"award-info":[{"award-number":["HDMA-380801"]}],"id":[{"id":"10.13039\/100014810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014810","name":"Fondazione di Sardegna","doi-asserted-by":"publisher","award":["2022-2023"],"award-info":[{"award-number":["2022-2023"]}],"id":[{"id":"10.13039\/100014810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jhepr.2025.101416","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T03:22:06Z","timestamp":1743909726000},"page":"101416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting EIF4A1 is effective against human intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"7","author":[{"given":"Wunan","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6408-3613","authenticated-orcid":false,"given":"Antonio","family":"Cigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Galleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3712-4149","authenticated-orcid":false,"given":"Isabella","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-1138","authenticated-orcid":false,"given":"Sara Martina","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Cibali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Mario","family":"Pes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Schloesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9834-4356","authenticated-orcid":false,"given":"Elena","family":"Pizzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4857-4276","authenticated-orcid":false,"given":"Anna","family":"Saborowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-8060","authenticated-orcid":false,"given":"Gianluigi","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Evert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc Johannes Wilhelmus","family":"van der Laan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9908-6673","authenticated-orcid":false,"given":"Monique Maria Andrea","family":"Verstegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6038-8567","authenticated-orcid":false,"given":"Diego Francesco","family":"Calvisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101416_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/1078-0432.CCR-14-3296","article-title":"Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma","volume":"22","author":"Moeini","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhepr.2025.101416_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101416_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jso.24720","article-title":"Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis","volume":"116","author":"Kim","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jhepr.2025.101416_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101416_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhepr.2025.101416_bib6","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.2217\/fon-2020-0299","article-title":"Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions\/translocations: the PROOF 301 trial","volume":"16","author":"Makawita","year":"2020","journal-title":"Future Oncol"},{"key":"10.1016\/j.jhepr.2025.101416_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2206834","article-title":"Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma","volume":"388","author":"Goyal","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101416_bib8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.jhepr.2025.101416_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/liv.14085","article-title":"Molecular perturbations in cholangiocarcinoma: is it time for precision medicine?","volume":"39","author":"Braconi","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101416_bib10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc2824","article-title":"Translational control in cancer","volume":"10","author":"Silvera","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhepr.2025.101416_bib11","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032896","article-title":"Translational control in cancer","volume":"11","author":"Robichaud","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jhepr.2025.101416_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrm2838","article-title":"The mechanism of eukaryotic translation initiation and principles of its regulation","volume":"11","author":"Jackson","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2025.101416_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","article-title":"The plasticity of mRNA translation during cancer progression and therapy resistance","volume":"21","author":"Fabbri","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhepr.2025.101416_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s13059-014-0476-1","article-title":"Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation","volume":"15","author":"Rubio","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jhepr.2025.101416_bib15","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1038\/s41467-019-13086-5","article-title":"eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma","volume":"10","author":"Chan","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2025.101416_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.celrep.2012.02.010","article-title":"Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis","volume":"1","author":"Lin","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhepr.2025.101416_bib17","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/s41375-021-01308-z","article-title":"Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 and exerts anti-leukemia activity in AML","volume":"35","author":"Nishida","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jhepr.2025.101416_bib18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.molcel.2018.11.026","article-title":"The translation inhibitor rocaglamide targets a bimolecular cavity between eIF4A and polypurine RNA","volume":"73","author":"Iwasaki","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhepr.2025.101416_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature17978","article-title":"Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor","volume":"534","author":"Iwasaki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2025.101416_bib20","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.chembiol.2019.08.008","article-title":"Amidino-rocaglates: a potent class of eIF4A inhibitors","volume":"26","author":"Chu","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.jhepr.2025.101416_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature13485","article-title":"RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer","volume":"513","author":"Wolfe","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2025.101416_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172503","article-title":"Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer","volume":"133","author":"Zhao","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2025.101416_bib23","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/IGC.0000000000000152","article-title":"Decreased expression of EIF4A1 after preoperative brachytherapy predicts better tumor-specific survival in cervical cancer","volume":"24","author":"Liang","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jhepr.2025.101416_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.542","article-title":"The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape","volume":"6","author":"Modelska","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2025.101416_bib25","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/ijms24032055","article-title":"eIF4A1 is a prognostic marker and actionable target in human hepatocellular carcinoma","volume":"24","author":"Steinmann","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2025.101416_bib26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/abbs\/gmz168","article-title":"High intratumoral expression of eIF4A1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer","volume":"52","author":"Gao","year":"2020","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.jhepr.2025.101416_bib27","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1021\/acs.jmedchem.0c00182","article-title":"Design of development candidate eFT226, a first in class inhibitor of eukaryotic initiation factor 4A RNA helicase","volume":"63","author":"Ernst","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhepr.2025.101416_bib28","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2025.101416_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.actbio.2022.11.038","article-title":"Extracellular matrix drives tumor organoids toward desmoplastic matrix deposition and mesenchymal transition","volume":"158","author":"van Tienderen","year":"2023","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jhepr.2025.101416_bib30","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/ijc.34350","article-title":"Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: a role for IL-17A","volume":"152","author":"Lieshout","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhepr.2025.101416_bib31","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3390\/jpm12081270","article-title":"Wnt\/\u03b2-catenin-pathway alterations and homologous recombination deficiency in cholangiocarcinoma cell lines and clinical samples: towards specific vulnerabilities","volume":"12","author":"Scheiter","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jhepr.2025.101416_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hep4.1312","article-title":"Murine liver organoids as a genetically flexible system to study liver cancer in vivo and in vitro","volume":"3","author":"Saborowski","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101416_bib33","first-page":"739","article-title":"Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis","volume":"6","author":"DeGregori","year":"2006","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jhepr.2025.101416_bib34","first-page":"4464","article-title":"Pharmacologic inhibition of EIF4A blocks NRF2 synthesis to prevent osteosarcoma metastasis","volume":"30","author":"Lizardo","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2025.101416_bib35","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","article-title":"Mechanisms of BCL-2 family proteins in mitochondrial apoptosis","volume":"24","author":"Czabotar","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2025.101416_bib36","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/liv.15392","article-title":"Bcl-x(L) as prognostic marker and potential therapeutic target in cholangiocarcinoma","volume":"42","author":"Hoffmeister-Wittmann","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101416_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4642","article-title":"Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy","volume":"7","author":"Leverson","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhepr.2025.101416_bib38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.molcel.2013.08.048","article-title":"BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response","volume":"51","author":"Sarosiek","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhepr.2025.101416_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/1535-7163.MCT-21-0474","article-title":"Overcoming gemcitabine resistance in pancreatic cancer using the BCL-X(L)-specific degrader DT2216","volume":"21","author":"Thummuri","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jhepr.2025.101416_bib40","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/s41591-019-0668-z","article-title":"A selective BCL-X(L) PROTAC degrader achieves safe and potent antitumor activity","volume":"25","author":"Khan","year":"2019","journal-title":"Nat Med"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592500093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592500093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:09:13Z","timestamp":1778904553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955592500093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S258955592500093X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101416","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting EIF4A1 is effective against human intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101416"}}